Ypsomed is a manufacturer of drug delivery devices for self-injection, specializing in injection pens, autoinjectors, and wearable injectors. Its devices deliver a broad range of liquid therapeutics, from established small-molecule drugs such as insulin to large-molecule biologics and the emerging class of GLP-1 receptor agonists for weight management and metabolic disease.
Ypsomed benefits from several secular growth drivers, including rising biologics development requiring injectables, expanding biosimilars, and surging GLP-1 drug demand.
Ypsomed and SHL Medical's focus on large-volume drugs could leave smaller biotech companies underserved, creating an opening for smaller competitors to gain traction.
|
Metric
|
YPSN
|
ATR
|
BDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.29 | 23.09 | 15.00 |
Price/Book Value | 6.81 | 3.06 | 2.18 |
Price/Sales | 7.21 | 2.10 | 2.75 |
Price/Cash Flow | 20.59 | 11.70 | 14.72 |
|
Metric
|
YPSN
|
ATR
|
BDX
|
|---|---|---|---|
Quick Ratio | 0.74 | 0.96 | 0.36 |
Current Ratio | 1.07 | 1.61 | 0.94 |
Interest Coverage | 76.55 | 7.95 | 3.53 |
|
Metric
|
YPSN
|
ATR
|
BDX
|
|---|---|---|---|
Return on Assets (Normalized) | 13.64% | 7.96% | 4.97% |
Return on Equity (Normalized) | 23.71% | 15.12% | 10.63% |
Return on Invested Capital (Normalized) | 18.06% | 10.95% | 7.26% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|v^sLz&?s | LOCK|?Lc | $158B | |||
| Becton Dickinson & Co
BDX
| LOCK|vF | LOCK|j<p# | $53B | |||
| ResMed Inc
RMD
| LOCK|tsPSxbR | LOCK|?yPf | $35B | |||
| Alcon Inc
ALC
| LOCK|v??K?%& | LOCK|l^>Y$ | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|PbJF<S$ | LOCK|kCfrG | $28B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|@n^PWlj | LOCK|%d | $28B | |||
| Solventum Corp
SOLV
| LOCK|<RC%t!? | LOCK|<r | $14B | |||
| Baxter International Inc
BAX
| LOCK|!%# | LOCK|bl&P | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|Y#&#^Z | LOCK|pNMv | $11B | |||
| Repligen Corp
RGEN
| LOCK|?zWGQPy | LOCK|QJbP! | $11B |
United States